Organon & Co | OGN - Ebitda





Ebitda Cambio Fecha
Bristol-Myers Squibb USD 2.88B 1.36B 2025-12
Celltrion KRW 17.79B 356.77B 2025-12
Cspc Pharmaceutical CNY 2.19B 21.88M 2024-12
Deva Holding AS TRY 882.9M 201.7M 2023-09
Dianthus Therapeutics USD -40.19M 5.36M 2025-09
Divis Laboratories Ltd INR 9.34B 440M 2026-03
Gilead Sciences USD 3.02B 1.01B 2025-12
Glaxosmithkline GBP 4.75B 1.52B 2025-09
Kangmei Pharma CNY -12.72M 30.02M 2026-03
Knight Therapeutics CAD 24.45M 3.46M 2025-12
Laboratorios Farma EUR 34.94M 102.95M 2025-06
Malin Corporation EUR -1.1M 200K 2024-12
Medical Developments International AUD 1.78M 3.78M 2024-12
Merck USD 6.3B 2.09B 2025-12
Neuren Pharmaceuticals AUD 11.14M 165.56M 2025-12
Novartis USD 5.84B 235M 2025-09
Organigram Holdings CAD 5.26M 884K 2025-12
Organon & Co USD 415M 32M 2026-03
Pharma Mar EUR 2.71M 42.25M 2026-03
Qiagen NV USD 249.69M 56.53M 2025-12
Sartorius EUR 267.3M 10.1M 2026-03
Sino Biopharmaceutical CNY 2.59B 1.57B 2024-12
Tilray USD 8.36M 1.82M 2025-09
Zealand Pharma A/S -727.47M 285.54M 2025-12